Rocket Pharmaceuticals
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $259,659,000.

Profit Margin

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT): Profit margin
2014 0 -9.53M
2015 0 -67.98M
2016 0 -42.85M
2017 0 -29.49M
2018 0 -74.51M
2019 0 -83.22M
2020 0 -146.66M
2021 0 -169.58M
2022 0 -219.38M
2023 0 -245.59M

RCKT Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0000000000
Cost of revenue
7.09M6.26M5.37M1.14M426K330K204K169K45K0
Gross profit
-7.09M-6.26M-5.37M-1.14M-426K-330K-204K-169K-45K0
Operating exp.
Research and development
186.34M165.57M125.47M106.38M58.62M53.27M14.19M31.98M12.55M5.59M
Selling and marketing
0000000000
Total operating expenses
259.65M223.84M166.24M134.30M75.90M70.97M26.73M41.87M20.39M7.70M
Operating income
-259.65M-224.34M-167.24M-134.30M-76.15M-71.15M-26.73M-41.87M-20.39M-7.70M
Other income (expenses), net
14.06M2.48M-1.82M-5.39M-1.11M801K-2.76M-975K-47.58M-1.82M
Income before tax
-245.59M-221.86M-169.06M-139.7M-77.27M-74.51M-29.49M-42.85M-67.98M-9.53M
Income tax expense
0-2.48M516K6.96M5.95M2.67M819K443K1.23M0
Net income
-245.59M-219.38M-169.58M-146.66M-83.22M-74.51M-29.49M-42.85M-67.98M-9.53M
Earnings per share
Basic EPS
-2.92-3.22-2.68-2.65-1.7-1.89-4.36-6.41-14.85-2.79
Diluted EPS
-2.92-3.22-2.68-2.65-1.7-1.89-4.36-6.41-14.85-2.79
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source